Search Results 171-180 of 4094 for ������������������������������������:VB20��������������������� ������

  1. A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors - Mayo Clinic

    Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...

  2. A Study to Evaluate the Effectiveness and Safety of Vibegron Administered Orally for 12 Weeks to Women with Irritable Bowel Syndrome - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of vibegron, a beta-3 adrenergic receptor (β3-AR) agonist, in the treatment of pain ...

  3. XmAb®20717 Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

    The purpose of this study is to investigate the safety and clinical activity of XmAb20717 alone or in combination with standard of care anticancer therapies in ...

  4. A Study to Investigate Biomarkers for Phenotyping of Neurodegenerative Disorders - Mayo Clinic

    About this study. The primary purpose of this study is to create a Mayo Clinic repository for neurodegenerative disorders such as Parkinson's disease (PD), ...

  5. Treatment of RLS/WED Symptoms Through Sensory Counter-stimulation - Mayo Clinic

    To evaluate, in a pilot fashion, efficacy and tolerability of electrical counter-stimulation using the Scrambler device in alleviating uncomfortable sensations ...

  6. A Study to Increase Access to Exposure Therapy for Anxiety and Obsessive Compulsive Disorders Using A Low-Cost, Virtual Reality System - Mayo Clinic

    The purpose of this study is to evaluate the randomized controlled mixed methods of a Virtual Reality (VR) exposure therapy system in patients with anxiety and ...

  7. Publications

    Publications. Shanafelt TD, West CP, Sinsky C, Trockel M, Tutty M, Wang H, Carlasare LE, Dyrbye LN. Changes in Burnout and Satisfaction With Work-Life ...

  8. Is Our Microbiome a Predictor of Cardiac Risk - Mayo Clinic

    The purpose of this study is to compare the fecal microbiota of patients with mild, moderate and severe Coronary Artery Disease (CAD) by collecting stool and ...

  9. Breast cancer treatment Archives - Mayo Clinic News Network

  10. Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) - Mayo Clinic

    intravitreal aflibercept (2.0 mg) every 4 weeks. SCORE2 aims to determine if bevacizumab is non-inferior to aflibercept for the treatment of macular edema ...